Academic Journal
No retinopathy after orbital irradiation in patients with thyroid eye disease - a follow up study.
| Τίτλος: | No retinopathy after orbital irradiation in patients with thyroid eye disease - a follow up study. |
|---|---|
| Συγγραφείς: | Makhoul S; Department of Ophthalmology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.; Doctoral School of Clinical Medicine, University of Debrecen, Debrecen, Hungary., Aranyosi JK; Department of Ophthalmology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Csiki E; Department of Oncoradiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Urbancsek H; Department of Oncology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Nagy EB; Divison of Radiology and Imaging Science, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Erdei A; Division of Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Fodor M; Department of Ophthalmology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Kovacs A; Department of Oncoradiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Nagy EV; Division of Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Ujhelyi B; Department of Ophthalmology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.; Doctoral School of Clinical Medicine, University of Debrecen, Debrecen, Hungary. |
| Πηγή: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2025 Dec 10; Vol. 16, pp. 1720650. Date of Electronic Publication: 2025 Dec 10 (Print Publication: 2025). |
| Τύπος έκδοσης: | Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: [Lausanne : Frontiers Research Foundation] |
| Ιατρικοί όροι (MeSH): | Graves Ophthalmopathy*/radiotherapy , Retinal Diseases*/etiology , Retinal Diseases*/epidemiology , Radiation Injuries*/etiology , Radiation Injuries*/epidemiology , Orbit*/radiation effects, Humans ; Follow-Up Studies ; Male ; Female ; Middle Aged ; Adult ; Aged |
| Περίληψη: | Introduction: Thyroid eye disease (TED) is an autoimmune disease of the orbit. In moderate to severe active disease, orbital radiotherapy (ORT) is a treatment option. Diabetes is considered a relative contraindication because of potential induction of retinopathy. The purpose of this study was to decide if ORT remains a risk towards retinopathy in the era of linear accelerators with 3D computer aided design. Follow up examinations were performed to detect radiogenic retinopathy. Methods: Of the 151 patients who received ORT for TED between 2004-2020 at the University of Debrecen, 97 patients were available for follow up. In each case, 3D-based LINAC radiotherapy with a total dose of 20 Gy in 2 Gy daily fractions was administered. Eighteen patients had type 2 and one patient had type 1 diabetes. Median duration of diabetes was 16 (IQR:11.75-17.0) years; most recent HbA1c before irradiation was 6.55 (IQR:6.22-6.95) %. Ophthalmological follow up included slit-lamp and fundus examination, visual acuity, exophthalmometry and clinical activity score (CAS) calculation. Results: Median time between TED start and ORT was 2 (IQR:1-8) years. At the time of ORT, median TSH was 0.84 (IQR:0-1.41) mU/L, fT4 18 (IQR:12.15-25.40) pmol/L and fT3 6.5 (IQR:4.4-11.0) pmol/L, CAS was 5 (IQR:4-6). No diabetic retinopathy was present before ORT. The median follow-up period after completion of ORT was 60 (IQR:38-100) months. No patient developed retinopathy. Discussion: The risk of radiation-induced retinopathy after orbital irradiation, including well controlled diabetic patients, appears to be negligible. In the absence of pre-existing diabetic retinopathy and with good glycemic control ORT might be safe if linear accelerator with 3D planning is used. However, ophthalmic surveillance is still recommended. (Copyright © 2025 Makhoul, Aranyosi, Csiki, Urbancsek, Nagy, Erdei, Fodor, Kovacs, Nagy and Ujhelyi.) |
| Competing Interests: | The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. |
| References: | Eur Thyroid J. 2022 Dec 08;11(6):. (PMID: 36479875) Endocrine. 2024 Aug;85(2):576-583. (PMID: 38517640) Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S3-9. (PMID: 20171515) Front Endocrinol (Lausanne). 2022 May 25;13:816400. (PMID: 35692405) Strahlenther Onkol. 2021 Oct;197(10):885-894. (PMID: 33860819) AMA Arch Ophthalmol. 1955 Jan;53(1):94-104. (PMID: 13217551) Horm Metab Res. 2017 Oct;49(10):739-747. (PMID: 28922676) Int J Endocrinol Metab. 2019 Jan 27;17(1):e84427. (PMID: 30881470) J Endocrinol Invest. 1991 Nov;14(10):853-60. (PMID: 1802923) Thyroid. 2002 Mar;12(3):245-50. (PMID: 11952048) Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S20-7. (PMID: 20171513) Clin Oncol (R Coll Radiol). 2017 Feb;29(2):110-115. (PMID: 27908503) Front Endocrinol (Lausanne). 2020 Nov 30;11:615993. (PMID: 33329408) Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1143-1150. (PMID: 30537543) Graefes Arch Clin Exp Ophthalmol. 2016 May;254(5):991-8. (PMID: 26876240) J Clin Endocrinol Metab. 2003 Aug;88(8):3561-6. (PMID: 12915636) Ophthalmology. 2022 Apr;129(4):450-455. (PMID: 34895729) Br J Radiol. 2008 Apr;81(964):304-10. (PMID: 18250119) Eye (Lond). 2013 Mar;27(3):308-19. (PMID: 23412559) Dev Ophthalmol. 2013;52:114-23. (PMID: 23989132) Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):766-74. (PMID: 11697323) J Clin Endocrinol Metab. 2012 Nov;97(11):3857-65. (PMID: 22962421) Front Endocrinol (Lausanne). 2023 Dec 20;14:1300196. (PMID: 38174334) Radiat Oncol. 2017 Nov 6;12(1):171. (PMID: 29110673) Ann Endocrinol (Paris). 2018 Dec;79(6):656-664. (PMID: 30177259) J Endocrinol Invest. 2023 Jul;46(7):1305-1316. (PMID: 36802028) Curr Opin Ophthalmol. 2015 May;26(3):157-66. (PMID: 25730680) Pak J Med Sci. 2016 Mar-Apr;32(2):516-8. (PMID: 27182273) Saudi J Ophthalmol. 2018 Apr-Jun;32(2):139-145. (PMID: 29942184) Eye (Lond). 2020 Feb;34(2):279-284. (PMID: 31844169) Eur J Endocrinol. 2021 Aug 27;185(4):G43-G67. (PMID: 34297684) Eur J Endocrinol. 2008 Mar;158(3):273-85. (PMID: 18299459) Ophthalmology. 2004 Aug;111(8):1557-62. (PMID: 15288988) Nat Rev Endocrinol. 2020 Feb;16(2):104-116. (PMID: 31889140) Cancer Radiother. 2024 Jun;28(3):282-289. (PMID: 38906800) Clin Endocrinol (Oxf). 1997 Jul;47(1):9-14. (PMID: 9302365) N Engl J Med. 2010 Feb 25;362(8):726-38. (PMID: 20181974) Clin Endocrinol (Oxf). 2020 Oct;93(4):363-374. (PMID: 32691849) J Pers Med. 2024 Jul 22;14(7):. (PMID: 39064030) Front Endocrinol (Lausanne). 2019 Jan 17;9:810. (PMID: 30705666) Ophthalmic Plast Reconstr Surg. 2018 Jul/Aug;34(4S Suppl 1):S98-S104. (PMID: 29771752) |
| Contributed Indexing: | Keywords: diabetes; exophthalmos; radiotherapy; retinopathy; thyroid eye disease |
| Entry Date(s): | Date Created: 20251226 Date Completed: 20251226 Latest Revision: 20251228 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC12728236 |
| DOI: | 10.3389/fendo.2025.1720650 |
| PMID: | 41450582 |
| Βάση Δεδομένων: | MEDLINE |
καταχωρήστε σχόλιο πρώτοι!